GSK (GSK), Innoviva (INVA) announce once-daily Trelegy Ellipta gains expanded COPD indication in Europe

November 9, 2018 7:09 AM

GlaxoSmithKline plc (NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has authorised an expanded label ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found